Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections

MicroRNAs

2004 • 33,206 citations

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Statistical significance for genomewide studies

2003 • 9,411 citations

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

2003 • 8,139 citations

Most mammalian mRNAs are conserved targets of microRNAs

2008 • 8,043 citations

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

1983 • 6,923 citations

TM4: A Free, Open-Source System for Microarray Data Management and Analysis

2003 • 4,724 citations

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

2005 • 4,706 citations

RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

2008 • 2,230 citations

Cancer of the Ovary

2004 • 2,075 citations

MicroRNA Signatures in Human Ovarian Cancer

2007 • 1,361 citations

Ovarian Tumorigenesis

2004 • 1,182 citations

microRNAs exhibit high frequency genomic alterations in human cancer

2006 • 1,029 citations

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

2008 • 736 citations

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

2008 • 683 citations

Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial

2003 • 645 citations

International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma

2003 • 431 citations

MicroRNAs and the hallmarks of cancer

2006 • 364 citations

The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis

2008 • 354 citations

Lost in translation: an assessment and perspective for computational microRNA target identification

2009 • 321 citations

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

2009 • 314 citations

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

2009 • 270 citations

Implications of micro-RNA profiling for cancer diagnosis

2006 • 264 citations

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma

2010 • 241 citations

MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis

2007 • 216 citations

Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

2006 • 214 citations

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

2010 • 198 citations

Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study.

2010 • 184 citations

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients

2009 • 158 citations

Finding Optimal Cutpoints for Continuous Covariates with Binary and Time-to-Event Outcomes

2006 • 156 citations

MicroRNAs in ovarian cancer biology and therapy resistance

2010 • 144 citations

Analysis of Gene Expression in Early-Stage Ovarian Cancer

2008 • 42 citations

ΔNp63 expression is associated with poor survival in ovarian cancer

2007 • 40 citations

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer

2007 • 36 citations